As with any peptide therapy, individual results depend on a range of factors, including age, lifestyle, and overall health status
J Chem Health Risks
A 2003 study by Staresinic, Sebecic, Patrlj, and colleagues in Journal of Orthopaedic Research used a rat Achilles tendon transection model with BPC-157 administered intraperitoneally once daily at 10 g/kg, 10 ng/kg, or 10 pg/kg and reported improved load-to-failure, Young's modulus of elasticity, and Achilles functional index scores, reduced tendon defect size by day 14, and increased tendocyte outgrowth in vitro with specific numerical effect sizes and p-values not reported in the abstract
Evaluating the need for maximum dose Not every patient needs the 2.4 mg dose
Learn more about the experts behind our content on our Health Expert Team page.
Therefore oral MA and MM should be considered in the differential diagnosis of pigmented lesions in the oral mucosa in these populations